RTW Biotech Opportunities Ltd announced Tuesday that its annual general meeting will take place on June 11, 2026, at 2pm BST at 1st Floor Royal Chambers, St Julian’s Avenue in St Peter Port, Guernsey.
The notice of the annual general meeting was dispatched to shareholders on Monday, according to a press release statement. The company submitted a copy of the notice to the National Storage Mechanism for inspection.
The company’s annual report and audited financial statements for the year ended December 31, 2025, are available on its website.
Shareholders will not receive hard copy proxy forms by mail. Proxy votes can be submitted electronically via the Investor Centre app or web browser. Proxy votes must reach the company’s registrar by 2pm BST on June 9, 2026. CREST members can use the service provided by Euroclear.
Shares held by a broker or nominee must be voted by the broker according to shareholder instructions. Institutional investors may appoint a proxy electronically via the Proxymity platform.
Shareholders with questions related to the meeting business can submit queries to the company’s email address by 2pm BST on June 9, 2026.
The company’s Legal Entity Identifier is 549300Q7EXQQH6KF7Z84.
